Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan-Chyr Yang

Showing results (61-70 of 495) with videos related to

Pageof 50
Sort By:
Journal of Surgical Oncology|May 3, 2014
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimensionMong-Wei Lin, Chen-Tu Wu, Jin-Yuan Shih, et al.
Journal of Nanobiotechnology|March 31, 2026
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapyS-Ja Tseng, Ivan M Kempson, Yi-Cheng Ho, et al.
Chest|October 16, 2002
Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavageShih-Lung Cheng, Hou-Tai Chang, Hon-Ping Lau, et al.
Chest|January 18, 2002
Management of tension pneumatocele with high-frequency oscillatory ventilationHsiu-Nien Shen, Frank Leigh Lu, Huey-Dong Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 17, 2010
Impact of therapeutic interventions on survival of patients with hepatic hydrothoraxWei-Lun Liu, Ping-Hung Kuo, Shih-Chi Ku, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 14, 2003
Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazolePo-Ren Hsueh, Lee-Jene Teng, Pan-Chyr Yang, et al.
Molecular Therapy. Nucleic Acids|December 14, 2016
A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor EffectsWei-Yun Lai, Bo-Tsang Huang, Jen-Wei Wang, et al.
Annals of Surgical Oncology|March 20, 2014
Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancyMong-Wei Lin, Chen-Tu Wu, Shuenn-Wen Kuo, et al.
ERJ Open Research|July 19, 2017
Lung adenocarcinoma patients of young age have lower <i>EGFR</i> mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitorsShang-Gin Wu, Yih-Leong Chang, Chong-Jen Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2016
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinomaChing-Yao Yang, Mong-Wei Lin, Yih-Leong Chang, et al.
Pageof 50

Showing results (61-70 of 495) with videos related to

Sort By:
Pageof 50
Journal of Surgical Oncology|May 3, 2014
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimensionMong-Wei Lin, Chen-Tu Wu, Jin-Yuan Shih, et al.
Journal of Nanobiotechnology|March 31, 2026
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapyS-Ja Tseng, Ivan M Kempson, Yi-Cheng Ho, et al.
Chest|October 16, 2002
Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavageShih-Lung Cheng, Hou-Tai Chang, Hon-Ping Lau, et al.
Chest|January 18, 2002
Management of tension pneumatocele with high-frequency oscillatory ventilationHsiu-Nien Shen, Frank Leigh Lu, Huey-Dong Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 17, 2010
Impact of therapeutic interventions on survival of patients with hepatic hydrothoraxWei-Lun Liu, Ping-Hung Kuo, Shih-Chi Ku, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 14, 2003
Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazolePo-Ren Hsueh, Lee-Jene Teng, Pan-Chyr Yang, et al.
Molecular Therapy. Nucleic Acids|December 14, 2016
A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor EffectsWei-Yun Lai, Bo-Tsang Huang, Jen-Wei Wang, et al.
Annals of Surgical Oncology|March 20, 2014
Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancyMong-Wei Lin, Chen-Tu Wu, Shuenn-Wen Kuo, et al.
ERJ Open Research|July 19, 2017
Lung adenocarcinoma patients of young age have lower <i>EGFR</i> mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitorsShang-Gin Wu, Yih-Leong Chang, Chong-Jen Yu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2016
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinomaChing-Yao Yang, Mong-Wei Lin, Yih-Leong Chang, et al.
Pageof 50